Methicillin-Resistant Staphylococcus aureus

Methicillin-Resistant Staphylococcus aureus

Methicillin-Resistant Staphylococcus aureus

On this page

MRSA Overview - Superbug Spotlight

  • Definition: S. aureus resistant to methicillin, oxacillin & most β-lactams.
  • Mechanism: mecA gene encodes PBP2a, conferring broad β-lactam resistance.
  • Types & Features:
    • HA-MRSA (Healthcare-Associated): Nosocomial, often multi-drug resistant (MDR), causes severe invasive disease.
    • CA-MRSA (Community-Associated): Affects community, skin/soft tissue infections (SSTIs) common, frequently PVL toxin positive.
  • Significance & Epidemiology: Critical "superbug"; global threat causing difficult infections, ↑morbidity, ↑mortality, ↑healthcare burden. Common nosocomial & emerging community pathogen.

⭐ CA-MRSA: often more virulent (PVL), yet susceptible to more non-β-lactams (clindamycin, TMP-SMX) vs HA-MRSA.

Resistance Mechanism - Genetic Armor

  • mecA Gene: Cornerstone of resistance.
    • Encodes Penicillin-Binding Protein 2a (PBP2a).
    • PBP2a: Low affinity for β-lactams (e.g., methicillin, oxacillin, nafcillin, cephalosporins).
    • Allows continued cell wall synthesis in antibiotic presence.
  • SCCmec (Staphylococcal Cassette Chromosome mec):
    • Mobile genetic element carrying mecA.
    • Facilitates horizontal gene transfer of resistance.
    • Multiple types (e.g., I, II, III, IV, V) exist, influencing epidemiology.

⭐ SCCmec types II & III are often linked to hospital-acquired MRSA (HA-MRSA), while type IV is common in community-acquired MRSA (CA-MRSA). MRSA resistance mechanisms diagram

Clinical Manifestations - MRSA's Attack Plan

  • Skin & Soft Tissue Infections (SSTIs): Most frequent.
    • Localized, pus-filled: Abscesses (hallmark), furuncles, carbuncles.
    • Spreading infections: Cellulitis, impetigo, erysipelas.
    • Complicated: Surgical site infections (SSIs), necrotizing fasciitis (rare but severe).
  • Invasive & Systemic Infections: High morbidity/mortality.
    • Bacteremia/Sepsis: Can rapidly progress to septic shock.
    • Pneumonia:
      • CA-MRSA: Severe, necrotizing pneumonia (often post-influenza), PVL toxin associated.
      • HA-MRSA: Common cause of Ventilator-Associated Pneumonia (VAP).
    • Infective Endocarditis (IE): Especially in IV drug users (IVDU) & patients with prosthetic valves.
    • Musculoskeletal: Osteomyelitis, septic arthritis.
    • Device-related: Catheter-associated UTIs. MRSA Necrotizing Pneumonia Pathway

⭐ CA-MRSA is often associated with Panton-Valentine Leukocidin (PVL) toxin, enhancing virulence and causing tissue necrosis in severe skin infections and necrotizing pneumonia.

Diagnosis & Management - Unmask & Combat

  • Diagnosis:
    • Screening: Cefoxitin disc diffusion (30µg) is preferred; zone ≤21mm for S. aureus indicates resistance.
    • Gold Standard: PCR for mecA gene (detects PBP2a directly).
    • Rapid Tests: PBP2a latex agglutination for quick PBP2a detection; chromogenic agars for direct MRSA identification.
  • Management Approach:
  • Key Antimicrobials:
    • Vancomycin: Primary for HA-MRSA & severe infections.
    • Linezolid: Good oral bioavailability; for VRE, MRSA.
    • Daptomycin: Bactericidal; avoid in pneumonia (surfactant inactivation).
    • Ceftaroline: Anti-MRSA cephalosporin.
  • Decolonization: Nasal mupirocin for carriers to reduce transmission.

⭐ The mecA gene confers resistance by encoding Penicillin-Binding Protein 2a (PBP2a), which has low affinity for β-lactam antibiotics.

Prevention & Control - Fortifying Defenses

  • Hand Hygiene: Cornerstone! Alcohol-based hand rubs (ABHR) or soap & water.
  • Contact Precautions: Gown, gloves for patient/environment contact. Patient isolation/cohorting.
  • Environmental Disinfection: Regular cleaning of shared equipment & high-touch surfaces.
  • Screening: Active surveillance cultures (e.g., nasal swabs) for high-risk admissions.
  • Decolonization: Intranasal mupirocin, topical chlorhexidine baths for identified carriers.
  • Antimicrobial Stewardship: Optimize antibiotic selection, dose, duration.

⭐ Strict adherence to hand hygiene and contact precautions is paramount in preventing MRSA transmission.

High‑Yield Points - ⚡ Biggest Takeaways

  • MRSA resistance is primarily due to the mecA gene, which encodes an altered penicillin-binding protein, PBP2a.
  • The mecA gene is located on a mobile genetic element called Staphylococcal Cassette Chromosome mec (SCCmec).
  • Vancomycin is the drug of choice; alternatives for resistant strains include Linezolid and Daptomycin.
  • Cefoxitin disc diffusion test is the recommended phenotypic method for MRSA screening.
  • Confirmation involves detection of the mecA gene (e.g., PCR) or PBP2a (e.g., latex agglutination).
  • Community-acquired MRSA (CA-MRSA) often carries the Panton-Valentine Leukocidin (PVL) toxin and may be susceptible to non-β-lactams like clindamycin or TMP-SMX.
  • MRSA is a major cause of nosocomial infections, including pneumonia and surgical site infections.
Rezzy AI Tutor

Have doubts about this lesson?

Ask Rezzy, our AI tutor, to explain anything you didn't understand

Practice Questions: Methicillin-Resistant Staphylococcus aureus

Test your understanding with these related questions

A patient develops an infection of methicillin resistant Staphylococcus aureus. All of the following can be used to treat this infection except

1 of 5

Flashcards: Methicillin-Resistant Staphylococcus aureus

1/8

Tube and Agar dilution method are _____ methods to test antibiotic sensitivity.

TAP TO REVEAL ANSWER

Tube and Agar dilution method are _____ methods to test antibiotic sensitivity.

dilution

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start For Free
Methicillin-Resistant Staphyloco... - Free Indian Medical PG